Literature DB >> 18642141

Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis.

Kirsty J McLean1, Andrew W Munro.   

Abstract

The global spread of tuberculosis (TB) has been fuelled by the development of strains of the causative bacterium (Mycobacterium tuberculosis, Mtb) that are resistant to all the leading drugs. New TB therapies are desperately needed, but recent genome sequence, genetic and protein characterization studies have helped identify novel Mtb drug targets and key biochemical pathways for strategic intervention. Of particular interest are the multiple cytochrome P450 (P450) enzymes encoded in the Mtb genome. Structural, biochemical and mechanistic studies on these systems have demonstrated their potential as antitubercular targets, as well as revealing novel aspects of P450 form and function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642141     DOI: 10.1080/03602530802186389

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  15 in total

1.  Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling.

Authors:  Griselda Tudó; Ken Laing; Denis A Mitchison; Philip D Butcher; Simon J Waddell
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

Review 2.  The Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2009-07-25       Impact factor: 4.013

3.  The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.

Authors:  Kirsty J McLean; Pierre Lafite; Colin Levy; Myles R Cheesman; Natalia Mast; Irina A Pikuleva; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

4.  A novel indigoid anti-tuberculosis agent.

Authors:  Larry L Klein; Valentina Petukhova; Baojie Wan; Yuehong Wang; Bernard D Santasiero; David C Lankin; Guido F Pauli; Scott G Franzblau
Journal:  Bioorg Med Chem Lett       Date:  2013-11-21       Impact factor: 2.823

Review 5.  Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Paul R Ortiz de Montellano
Journal:  J Inorg Biochem       Date:  2018-01-12       Impact factor: 4.155

6.  Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1.

Authors:  Hugues Ouellet; Petrea M Kells; Paul R Ortiz de Montellano; Larissa M Podust
Journal:  Bioorg Med Chem Lett       Date:  2010-11-05       Impact factor: 2.823

7.  Reaction of Mycobacterium tuberculosis cytochrome P450 enzymes with nitric oxide.

Authors:  Hugues Ouellet; Jérôme Lang; Manon Couture; Paul R Ortiz de Montellano
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

8.  Biochemical and structural characterization of CYP124: a methyl-branched lipid omega-hydroxylase from Mycobacterium tuberculosis.

Authors:  Jonathan B Johnston; Petrea M Kells; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

Review 9.  Hydrocarbon hydroxylation by cytochrome P450 enzymes.

Authors:  Paul R Ortiz de Montellano
Journal:  Chem Rev       Date:  2010-02-10       Impact factor: 60.622

Review 10.  Cholesterol metabolism: a potential therapeutic target in Mycobacteria.

Authors:  Areej Abuhammad
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.